Serum irisin levels in new-onset type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 100, Issue 1, 2013, Pages 96-101

  Choi, Yeon Kyung ^a   Kim, Mi Kyung ^b   Bae, Kwi Hyun ^a   Seo, Hyun Ae ^a   Jeong, Ji Yun ^a   Lee, Won Kee ^a   Kim, Jung Guk ^a   Lee, In Kyu ^a   Park, Keun Gyu ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

Adiponectin; Irisin; Myokine; Type 2 diabetes

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRISIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FIBRONECTINS; HUMANS; LOGISTIC MODELS; MALE; OBESITY; PPAR GAMMA; REPUBLIC OF KOREA; THERMOGENESIS; TRANSCRIPTION FACTORS;

EID: 84876736157     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.01.007     Document Type: Article

References (31)

1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health. Obes Res 1998, 6(Suppl. 2):51S-209S.
2. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104:787-794.
3. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007, 356:213-215.
4. Lazar M.A. How obesity causes diabetes: not a tall tale. Science 2005, 307:373-375.
5. Aldhahi W., Hamdy O. Adipokines inflammation, and the endothelium in diabetes. Curr Diab Rep 2003, 3:293-298.
6. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 2006, 4:263-273.
7. Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006, 64:355-365.
8. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
9. Esteve E., Ricart W., Fernandez-Real J.M. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009, 32(Suppl. 2):S362-S367.
10. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
11. Seale P., Conroe H.M., Estall J., Kajimura S., Frontini A., Ishibashi J., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2011, 121:96-105.
12. Almind K., Manieri M., Sivitz W.I., Cinti S., Kahn C.R. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci USA 2007, 104:2366-2371.
13. Lowell B.B., S-Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
14. Yang X., Enerback S., Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 2003, 11:1182-1191.
15. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012, 88:1379-1406.
16. Nielsen A.R., Pedersen B.K. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 2007, 32:833-839.
17. Broholm C., Pedersen B.K. Leukaemia inhibitory factor - an exercise-induced myokine. Exerc Immunol Rev 2010, 16:77-85.
18. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406.
19. Pedersen B.K., Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammation in the elderly. Scand J Med Sci Sports 2003, 13:56-62.
20. Pedersen B.K. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006, 42:105-117.
21. Speakman J.R., Selman C. Physical activity and resting metabolic rate. Proc Nutr Soc 2003, 62:621-634.
22. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002, 16:1879-1886.
23. Goto M., Terada S., Kato M., Katoh M., Yokozeki T., Tabata I., et al. cDNA cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochem Biophys Res Commun 2000, 274:350-354.
24. Wenz T., Rossi S.G., Rotundo R.L., Spiegelman B.M., Moraes C.T. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 2009, 106:20405-20410.
25. Bostrom P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
26. Report of a World Health Organization Consultation: use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011, 93:299-309.
27. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
28. Teufel A., Malik N., Mukhopadhyay M., Westphal H. Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. Gene 2002, 297:79-83.
29. Hittel D.S., Berggren J.R., Shearer J., Boyle K., Houmard J.A. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 2009, 58:30-38.
30. Ogasawara D., Shite J., Shinke T., Watanabe S., Otake H., Tanino Y., et al. Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus. Circ J 2009, 73:343-351.
31. Yamauchi T., Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 2008, 32(Suppl. 7):S13-S18.